On January 19 and January 23, 2017, the 15th and 16th of 18 participants were treated in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif. The 17th participant was officially enrolled on January 30. Led by Principal Investigator Phil Wolfson, M.D., with Co-Therapist Julane Andries, L.M.F.T., this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety associated with diagnosis of a life-threatening illness in 18 participants. Learn more…
